Vimentin (encoded by VIM) was the most significantly upregulated gene at relapse in dogs and increased vimentin has been associated with a CHOP resistant phenotype in human DLBCL cells implicating vimentin as a putative factor mediating invasive, multi-drug resistant disease58. Here, VIM is linked to diffuse large B-cell lymphoma.